ZA981847B - New benzoxazinedione derivatives a method of producing them and the use thereof - Google Patents

New benzoxazinedione derivatives a method of producing them and the use thereof

Info

Publication number
ZA981847B
ZA981847B ZA981847A ZA981847A ZA981847B ZA 981847 B ZA981847 B ZA 981847B ZA 981847 A ZA981847 A ZA 981847A ZA 981847 A ZA981847 A ZA 981847A ZA 981847 B ZA981847 B ZA 981847B
Authority
ZA
South Africa
Prior art keywords
producing
new
benzoxazinedione
derivatives
benzoxazinedione derivatives
Prior art date
Application number
ZA981847A
Other languages
English (en)
Inventor
Lothar Heinisch
Steffen Wittmann
Ute Moellmann
Rolf Reissbrodt
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of ZA981847B publication Critical patent/ZA981847B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ZA981847A 1997-03-05 1998-03-04 New benzoxazinedione derivatives a method of producing them and the use thereof ZA981847B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19708846A DE19708846A1 (de) 1997-03-05 1997-03-05 Neue Benzoxazindionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ZA981847B true ZA981847B (en) 1998-09-08

Family

ID=7822233

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981847A ZA981847B (en) 1997-03-05 1998-03-04 New benzoxazinedione derivatives a method of producing them and the use thereof

Country Status (30)

Country Link
US (1) US6013647A (no)
EP (1) EP0863139B1 (no)
JP (1) JPH10316666A (no)
KR (1) KR19980079905A (no)
CN (1) CN1075064C (no)
AR (1) AR010125A1 (no)
AT (1) ATE200080T1 (no)
AU (1) AU737760B2 (no)
BR (1) BR9802894A (no)
CA (1) CA2230965A1 (no)
CO (1) CO4950613A1 (no)
CZ (1) CZ65098A3 (no)
DE (2) DE19708846A1 (no)
DK (1) DK0863139T3 (no)
ES (1) ES2157617T3 (no)
GR (1) GR3035834T3 (no)
HK (1) HK1015763A1 (no)
HU (1) HUP9800472A3 (no)
IL (1) IL123535A (no)
NO (1) NO310657B1 (no)
NZ (1) NZ329883A (no)
PE (1) PE71799A1 (no)
PL (1) PL325142A1 (no)
PT (1) PT863139E (no)
RU (1) RU2184114C2 (no)
SI (1) SI0863139T1 (no)
SK (1) SK28898A3 (no)
UA (1) UA45414C2 (no)
UY (1) UY24915A1 (no)
ZA (1) ZA981847B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6115157A (en) * 1997-12-24 2000-09-05 Nortel Networks Corporation Methods for equalizing WDM systems
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
DE10111164A1 (de) * 2001-03-01 2002-09-05 Gruenenthal Gmbh Neue substituierte Catecholderivate abgeleitet von mehrbasischen sekundären Aminosäuren, Verfahren zu ihrer Herstellung und ihre Anwendung
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
US20040186087A1 (en) * 2003-03-20 2004-09-23 Ceramoptec Industries, Inc. Siderophore conjugates of photoactive dyes for photodynamic therapy
ES2330670T3 (es) 2005-05-25 2009-12-14 Actelion Pharmaceuticals Ltd. Nuevos derivados antibioticos.
TWI603962B (zh) 2016-09-10 2017-11-01 國立清華大學 含硫噁嗪化合物及其合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047573A (en) * 1962-07-31 N-alkylamido substituted
FR831710A (fr) * 1937-02-02 1938-09-13 Procédé de fabrication de fermetures à tirette, à partir de matière non métallique
GB878603A (en) * 1959-07-01 1961-10-04 Nippon Shinyaku Co Ltd Salicyclic acid derivatives
DE1147583B (de) * 1959-07-01 1963-04-25 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von 2, 4-Dioxo-dihydro-1, 3-benzoxazinyl-(3)-essigsaeure-dialkylamiden
US4338436A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl)amino]acetamido]cephalosporins
US4338439A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins
US4319028A (en) * 1976-08-26 1982-03-09 Eli Lilly And Company 7-(2-(Substituted benzoyl)amino)acetamido)cephalosporins
GB8811055D0 (en) * 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
DE4102234A1 (de) * 1991-01-23 1992-07-30 Dresden Arzneimittel Neue (alpha)-aminochinolinoyl-(3)-penicilline, verfahren zu deren herstellung und diese enthaltende antibakterielle mittel
IT1256023B (it) * 1992-06-10 1995-11-20 Italfarmaco Spa Derivati benzossazinonici e benzotiazinonici ad attivita' cardiovascolare
DE19654920A1 (de) * 1996-06-26 1998-01-08 Gruenenthal Gmbh Neue synthetische Catecholderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
RU2184114C2 (ru) 2002-06-27
AU737760B2 (en) 2001-08-30
UA45414C2 (uk) 2002-04-15
HUP9800472A3 (en) 2000-09-28
DE19708846A1 (de) 1998-09-17
IL123535A0 (en) 1998-10-30
HK1015763A1 (en) 1999-10-22
US6013647A (en) 2000-01-11
NZ329883A (en) 1999-04-29
DK0863139T3 (da) 2001-04-30
ES2157617T3 (es) 2001-08-16
UY24915A1 (es) 2000-12-29
PT863139E (pt) 2001-07-31
PE71799A1 (es) 1999-08-07
HU9800472D0 (en) 1998-04-28
EP0863139B1 (de) 2001-03-28
NO980929L (no) 1998-09-07
JPH10316666A (ja) 1998-12-02
SK28898A3 (en) 1998-11-04
ATE200080T1 (de) 2001-04-15
DE59800568D1 (de) 2001-05-03
EP0863139A1 (de) 1998-09-09
HUP9800472A2 (hu) 1999-06-28
AR010125A1 (es) 2000-05-17
PL325142A1 (en) 1998-09-14
KR19980079905A (ko) 1998-11-25
AU5645598A (en) 1998-09-10
CN1075064C (zh) 2001-11-21
NO310657B1 (no) 2001-08-06
GR3035834T3 (en) 2001-08-31
NO980929D0 (no) 1998-03-04
SI0863139T1 (en) 2001-06-30
CO4950613A1 (es) 2000-09-01
CN1195664A (zh) 1998-10-14
BR9802894A (pt) 2000-03-21
IL123535A (en) 2000-10-31
CZ65098A3 (cs) 1998-09-16
CA2230965A1 (en) 1998-09-05

Similar Documents

Publication Publication Date Title
EP1018750A4 (en) RESISTANCE AND ITS MANUFACTURING PROCESS
AU1874695A (en) Retroreflective article and method of making the same
HUP0100103A3 (en) Methods for producing triazolinethione derivatives and the novel intermediates
HUP0004946A3 (en) Method for producing triazolinthion derivatives and the novel intermediates
GB2346823B (en) Reamer and method of using the same
HK1005640A2 (en) Method of making a model
PL312692A1 (en) New derivatives of dialkoxy-pyridinol-benzimidazole
GB9506181D0 (en) Method of manufacture of a structure and a structural member for use in the method
ZA981847B (en) New benzoxazinedione derivatives a method of producing them and the use thereof
GB9411176D0 (en) Decorative method and materials
HUP9700991A3 (en) Taxoid derivatives and method of producing thereof
GB2320370B (en) Coupled line and method of producing the same
GB2300974B (en) A heatsink and a method of forming the same
GB2303862B (en) A ceiling and a method of constructing the same
ZA989780B (en) Novel crystal of depsipeptide derivative and a method for producing the same
PL336768A1 (en) Method of continuously producing dihydroxydiphenylalkanes
ZA988284B (en) A method of producing an article
EP0711904A3 (en) Sliding part and manufacturing process
EP0727304A3 (en) Process for the production of structural components and component produced thereafter
HUT73184A (en) Method of manufacturing the cycloheptimidazole derivatives
ZA98119B (en) Process for the preparation of 4"-deoxyerythromycins a and b
GB9902306D0 (en) Structure and a method of its manufacture
ZA959204B (en) Oxazolidinedioe derivatives their production and use
HUP0003497A3 (en) Method for producing substituted-2-nitroguanidine derivatives and their intermediates
IL113766A0 (en) Metabolite and derivatives